Not only can they hit the universal cellular energy metabolism system by uncoupling the membranes of the mitochondria and subsequently generating ROS, but they are also potentially effective against the Bcl-2-enriched breast cancer subtype. The gene discussed is BCL2; the disease is breast carcinoma.